Shire nabbed FDA approval for its new long-acting ADHD drug, becoming the second drugmaker in two days to win a nod in that field. Shire’s drug, Mydayis, has been a long time coming. Previously known ...
After six months of relentless pursuit, Shire SHPG finally announced that it will acquire Baxalta, Inc. BXLT for $32 billion. The boards of directors of both companies have agreed to the merger. We ...
If there was ever a licensed property that feels right at home with a family-friendly farming simulator game, it’s The Lord of the Rings and author J.R.R. Tolkien’s iconic fantasy realm of ...
Looking for Tales of the Shire guides? Tales of the Shire is the Lord of the Rings game we never knew we needed. A cute, cozy farming sim like Stardew Valley or Animal Crossing, Tales of the Shire ...
Are Lord of the Rings games cursed now? As an avid Tolkien fanatic with multiple LotR tattoos and a bookshelf specifically for the author's fantasy work and posthumous derivations thereof, I grew up ...
Shire’s got a brand-new approval on its hands that could help it dominate the hereditary angioedema (HAE) market for years to come—and rack up blockbuster sales in the process. Thursday, the FDA green ...
From his earliest gaming memories playing Spyro 2 on the PlayStation, to being obsessed with the swing-out animations in Marvel's Spider-Man, Cameron has always been, and continues to be, in love with ...
The history of one of the world's biggest speciality and rare disease pharmaceutical companies Shire is known as one of the world's fastest growing specialty pharmaceutical companies. Today, it has ...
Lucas is a writer and narrative designer from Argentina with over 15 years of experience writing for games and news. He keeps a watchful eye at the gaming world and loves to write about the hottest ...
Simply sign up to the US companies myFT Digest -- delivered directly to your inbox. Shire has agreed a $32bn takeover of Baxalta in a sign that the two-year-old boom in pharmaceuticals mergers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results